Search

everythinglearnresearchcommunity

for

Search:↓

Continued research and awareness are needed to improve treatments for androgen-dependent diseases.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Most patients improved with oral contraceptives, but some needed additional treatment.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Men with coeliac disease may have hormone imbalances that could affect sexual function, but these can improve with better gut health.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Balding and low testosterone increase risk of urinary stones.

Ayurvedic plants may help treat PCOD by affecting hormones and ovarian health.

Combining modern and Unani treatments may offer better care for hirsutism in PCOS.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Both metformin and pioglitazone improve PCOS symptoms, but pioglitazone is a good alternative for those who can't take metformin.

PCOS in teens causes hormonal imbalances, irregular periods, and can lead to infertility and other health issues.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Metformin helps improve symptoms and reproductive outcomes in people with polycystic ovary syndrome.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Green tea may help relieve PCOS symptoms, but more research is needed.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

The document concludes that early diagnosis and treatment of PCOS in teenagers is important for managing symptoms and preventing long-term health problems.

Taking metformin with intense pulsed light therapy improves hair removal for women with PCOS.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.